Inclusion body myositis.

Steven A Greenberg
Author Information
  1. Steven A Greenberg: Division of Neuromuscular Disease, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. sagreenberg@partners.org

Abstract

PURPOSE OF REVIEW: Sporadic inclusion body myositis (sIBM) is a poorly understood immune and degenerative disease of skeletal muscle. Here, current opinion of the nature of this disease is summarized.
RECENT FINDINGS: Recent findings for sIBM include further characterization of muscle involvement through magnetic resonance imaging, the role of muscle as a host for immune cells, progress in the role of extranuclear TDP-43 in causing cellular injury, and the discovery of a new sIBM autoantibody.
SUMMARY: sIBM understanding continues to advance, with progress regarding the mechanism of this disease.

MeSH Term

Autoantibodies
B-Lymphocytes
Cell Nucleus
DNA-Binding Proteins
Humans
Magnetic Resonance Imaging
Myositis, Inclusion Body
T-Lymphocytes

Chemicals

Autoantibodies
DNA-Binding Proteins

Word Cloud

Created with Highcharts 10.0.0sIBMdiseasemusclebodymyositisimmuneroleprogressPURPOSEOFREVIEW:SporadicinclusionpoorlyunderstooddegenerativeskeletalcurrentopinionnaturesummarizedRECENTFINDINGS:RecentfindingsincludecharacterizationinvolvementmagneticresonanceimaginghostcellsextranuclearTDP-43causingcellularinjurydiscoverynewautoantibodySUMMARY:understandingcontinuesadvanceregardingmechanismInclusion

Similar Articles

Cited By